Pharmaceutical Health Outcomes and Policy
Ph.D. in Pharmaceutical Health Outcomes and Policy (PHOP) Concentration
As a research area, Pharmaceutical Health Outcomes and Policy (PHOP) evaluates the cost, access, and quality of pharmaceutical care from clinical, sociobehavioral, economic, organizational, and technological perspectives. Traditional and innovative areas of pharmaceutical health outcomes research include pharmacoepidemiology, pharmacoeconomics, comparative effectiveness research, patient-centered outcomes research and translational research.
The graduate program offers structured learning and experiences in health care systems, sociobehavioral sciences, health care quality, biostatistics, advanced regression analyses, research methods and design, pharmacoepidemiology, and pharmacoeconomics. Elective courses such as patient-reported outcomes and risk adjustment provide advanced learning experiences, along with the opportunities to participate in grant proposal writing as well as teaching and research practicums.
- Yearly enrollment on a competitive basis
- Financial assistance for qualified applicants based on availability
- Collaboration with Texas Medical Center health care institutions
- Collaboration with the pharmaceutical industry
The University of Houston (UH) is an urban teaching and research institution that sets standards of excellence in education, research and service. The UH College of Pharmacy has trained pharmacists and researchers to work in health care for over 75 years. The Texas Medical Center (TMC) is the world’s largest medical and health center, with 42 member institutions specializing in every aspect of health care.
This graduate program is enhanced through its interaction and collaboration with the world-renowned institutions at the TMC, such as the University of Texas Health Science Center (UTHealth) and the University of Texas MD Anderson Cancer Center, and other UH colleges and departments, including the C.T. Bauer College of Business Administration's MBA program (fully accredited by the prestigious American Assembly of Collegiate Schools of Business), and the College of Liberal Arts and Social Sciences' Department of Economics.
